The table below shows CorMedix Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$42.38M
$19.74M
-$17.31M
-$10.39M
-$6.74M
-$6.69M
Capital expenditure
$729.00K
$10.00K
$61.31K
$14.77K
$4.32K
$13.08K
Investing cash flow
$2.96M
-$195.00K
$8.94M
-$14.69M
-$4.19M
-$526.02K
Dividends paid
-
-
-
-
CRMD operating cash flow (10-K history)
CorMedix Inc. reported operating cash flow of $175.05M for fiscal year 2025. That is up 445.8% from -$50.62M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$22.27M (FY 2016) to $175.05M. Figures come from the company's audited annual reports as filed with the SEC.